secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2025-11-05T23:59:59+00:00
Accession:  0001193125-25-265750
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen Q3 revenue $92.4M (+4% YoY); adj. EBITDA positive $2.3M; raises FY guidance
--------------------------------------------------------------------------------

- Revenue $92.4M, up 4% YoY; seventh consecutive quarter of mid-single-digit growth.
- GAAP net loss $5.3M vs $6.0M loss; adjusted net loss $0.5M vs $2.6M loss.
- Adjusted EBITDA $2.3M (third consecutive positive quarter); full-year adj. EBITDA guidance raised to ~$2M.
- Cash $124.5M, no debt; initiated limited U.S. release of Simeox airway clearance device.
- Gross margin 44.7% down from 46.5% due to higher B2B sales mix.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000119312525265750/0001193125-25-265750-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000119312525265750/ingn-20251105.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-265750

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer